Table 1 General characteristics of participants.
Characteristics | Total participants | ||
|---|---|---|---|
CRS total (n = 6,393) | Control (n = 25,572) | Standardized difference | |
CRS with nasal polyps & control (n, %) | 3304 (51.7) | 13,216 (51.7) | |
CRS without nasal polyps & control (n, %) | 3089 (48.3) | 12,356 (48.3) | |
Age (years old, n, %) | 0.00 | ||
40–44 | 424 (6.6) | 1696 (6.6) | |
45–49 | 1224 (19.2) | 4896 (19.2) | |
50–54 | 1419 (22.2) | 5676 (22.2) | |
55–59 | 1259 (19.7) | 5036 (19.7) | |
60–64 | 933 (14.6) | 3732 (14.6) | |
65–69 | 626 (9.8) | 2504 (9.8) | |
70–74 | 343 (5.4) | 1372 (5.4) | |
75–79 | 126 (2.0) | 504 (2.0) | |
80–84 | 31 (0.5) | 124 (0.5) | |
≥ 85 | 8 (0.1) | 32 (0.1) | |
Sex (n, %) | 0.00 | ||
Male | 3880 (60.7) | 15,520 (60.7) | |
Female | 2513 (39.3) | 10,052 (39.3) | |
Income (n, %) | 0.00 | ||
1 (lowest) | 753 (11.8) | 3012 (11.8) | |
2 | 767 (12.0) | 3068 (12.0) | |
3 | 981 (15.3) | 3924 (15.3) | |
4 | 1355 (21.2) | 5420 (21.2) | |
5 (highest) | 2537 (39.7) | 10,148 (39.7) | |
Region of residence (n, %) | 0.00 | ||
Urban | 2999 (46.9) | 11,996 (46.9) | |
Rural | 3394 (53.1) | 13,576 (53.1) | |
Total cholesterol level (mg/dL, mean, SD) | 198.0 (37.0) | 199.4 (38.0) | 0.04 |
SBP (mmHg, mean, SD) | 125.5 (16.4) | 126.8 (17.1) | 0.07 |
DBP (mmHg, mean, SD) | 78.7 (10.8) | 79.2 (11.1) | 0.05 |
Fasting blood glucose level (mg/dL, mean, SD) | 98.5 (31.4) | 100.1 (33.1) | 0.05 |
Obesitya (n, %) | 0.07 | ||
Underweight | 111 (1.7) | 549 (2.2) | |
Normal | 2061 (32.2) | 8755 (34.2) | |
Overweight | 1906 (29.8) | 7124 (27.9) | |
Obese I | 2144 (33.5) | 8349 (32.7) | |
Obese II | 171 (2.7) | 795 (3.1) | |
Smoking status (n, %) | 0.10 | ||
Nonsmoker | 4285 (67.0) | 16,685 (65.3) | |
Past smoker | 841 (13.2) | 2829 (11.1) | |
Current smoker | 1267 (19.8) | 6058 (23.7) | |
Alcohol consumption (n, %) | 0.03 | ||
< 1 time a week | 4424 (69.2) | 17,287 (67.6) | |
≥ 1 time a week | 1969 (30.8) | 8,285 (32.4) | |
CCI score (score, n, %) | 0.10 | ||
0 | 4412 (69.0) | 18,686 (73.1) | |
1 | 905 (14.2) | 3012 (11.8) | |
2 | 527 (8.2) | 1754 (6.9) | |
≥ 3 | 549 (8.6) | 2120 (8.3) | |
Asthma (n, %) | 1910 (29.9) | 4175 (16.3) | 0.33 |
COPD (n, %) | 756 (11.8) | 1593 (6.2) | 0.20 |
1-y pre-ID pneumonia (n, %) | 0.00 | ||
0 times | 6209 (97.1) | 24,836 (97.1) | |
≥ 1 time | 184 (2.9) | 736 (2.9) | |
Post-ID pneumonia (mean, SD) | |||
First year-periods | 0.08 (0.67) | 0.05 (0.54) | 0.05 |
Second year-periods | 0.08 (0.57) | 0.05 (0.58) | 0.05 |
Third year-periods | 0.08 (0.65) | 0.05 (0.52) | 0.06 |
